Great honor for alcohol research at the CIMH: Prof. Dr. Falk Kiefer was honored with the "European Award for Excellence in Alcohol Research – Helmut Seitz Award" in Brussels. read more …

A new DFG-funded research group led by Prof. Simon Wiegert (Mannheim) and Prof. Tobias Brügmann (Göttingen) is investigating how G protein-coupled receptors (GPCRs) integrate environmental signals to regulate physiological and behavioral responses. The interdisciplinary consortium combines optogenetics, physiology, and cutting-edge signal transduction research to uncover fundamental principles of adaptive control in living systems. read more …

Prof. Dr. Rainer Spanagel, Scientific Director of the Institute of Psychopharmacology at the Central Institute of Mental Health, received the Jellinek Memorial Award at the Research Society on Alcohol (RSA) congress in New Orleans/USA in June for his outstanding achievements in the preclinical and translational development of pharmacotherapies for patients with alcohol addiction. read more …

Fighting brain tumors with immune cells – this is the goal of neurologist Dr. Dr. Lukas Bunse. This year, he received the Heinz Maier-Leibnitz Prize from the German Research Foundation (DFG). read more …

Interdisciplinary collaboration at the 2025 Hertie Network Symposium in Mannheim. The spring gathering focused on the latest advances in neurology and the translation of innovative technologies into clinical applications, under the theme Technology Advances and Translation in Neurology. read more …

Sven Wischnewski has been awarded the Myositis Young Investigator Award by the German Society for Muscle Diseases for his research on inclusion body myositis. He received the award at the 27^th DGM Congress in Giessen on March 20. read more …

On 17-19 February, the MCTN hosted an exciting Innovation Bootcamp & Equality, Diversity and Inclusion Workshop at the Mannheim Medical Faculty for the students of the GLIORESOLVE project, an EU-funded research project within the Horizon Europe programme focusing on glioblastoma. read more …

Engineered T cells targeting the glioblastoma antigen PTPRZ1 show potent, selective killing of tumor cells, particularly glioblastoma stem cells, without off-target effects. In experimental brain tumors, these TCR-T cells demonstrate efficacy, persistence, and a stem-cell memory phenotype, offering a promising new strategy for glioblastoma treatment. read more …

Child and adolescent psychiatrist and psychotherapist Tobias Banaschewski of the Central Institute of Mental Health, neurologist and MCTN director Michael Platten and former MCTN co-director Rolf-Detlef Treede are among the 2024 Highly Cited Researchers! This incredible achievement reflects their dedication, expertise, and outstanding contributions to their respective fields. read more …